Marbofloxacin
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB11426 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 26 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | interventricular septum aneurysm | KG + DL |
| 2 | pulmonary valve disease | KG + DL |
| 3 | orofacial clefting syndrome | KG + DL |
| 4 | Laubry-Pezzi syndrome | KG + DL |
| 5 | genetic syndromic Pierre Robin syndrome | KG + DL |
| 6 | disorder of fucoglycosan synthesis | KG + DL |
| 7 | Pierre Robin syndrome associated with a chromosomal anomaly | KG + DL |
| 8 | partial deletion of the long arm of chromosome 22 | KG + DL |
| 9 | Jeune syndrome situs inversus | KG + DL |
| 10 | partial deletion of the long arm of chromosome 7 | KG + DL |
| 11 | mitral valve disease | KG + DL |
| 12 | heart disease | KG + DL |
| 13 | heart neoplasm | KG + DL |
| 14 | heart valve disease | KG + DL |
| 15 | heart conduction disease | KG + DL |
| 16 | congenital anomaly of ventricular septum | KG + DL |
| 17 | pericardium disease | KG + DL |
| 18 | patent ductus arteriosus-bicuspid aortic valve-hand anomalies syndrome | KG + DL |
| 19 | carcinoid heart disease | KG + DL |
| 20 | heart aneurysm | KG + DL |
| 21 | cor biloculare | KG + DL |
| 22 | myocardial rupture | KG + DL |
| 23 | cardiac anomalies-heterotaxy syndrome | KG + DL |
| 24 | white forelock with malformations | KG + DL |
| 25 | aortopulmonary window | KG + DL |
| 26 | microcephaly-cardiac defect-lung malsegmentation syndrome | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.